Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gastric Bypass vs Exenatide in T2D
NCT01435980Phase 4Unknown
- Start
- Feb 2008
- Primary completion
- Jan 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of exenatide in type 2 diabetes mellitus (T2DM) (3 arms). Primary endpoint: Clinical events at 1 year. Status: unknown.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01435980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01435980.